Mixed Results for Therapeutic Candidates for Platinum-Resistant Ovarian Cancer

TribeNews
By TribeNews Add a Comment 5 Views
0 Min Read

MedPage Today) — Promising therapies for platinum-resistant ovarian cancer produced mixed results in separate trials.
The AKT inhibitor afuresertib failed to improve progression-free survival (PFS) when added to paclitaxel for patients with…

Leave a Comment
Ads Blocker Image Powered by Code Help Pro

Ads Blocker Detected & This Is Prohibited!!!

We have detected that you are using extensions to block ads and you are also not using our official app. Your Account Have been Flagged and reported, pending de-activation & All your earning will be wiped out. Please turn off the software to continue

You cannot copy content of this app